Globally, technological innovations are increasingly being developed for and applied within the health and care sectors. New biotechnology applications, for example, are important for the development and use of medicines. But in addition to cures, another thing they are looking for within the care service sector is innovative technologies, for example the development of new, assistive devices. From the perspective of the Health & Care Services investment domain, LRM has been responding to this trend for several years.
InnoSer meets the growing demands for professional expertise and infrastructure for scientific research institutes and commercial companies. We offer laboratory services in the field of genetically modified (genetically altered, GA) in vivo and in vitro models for biomedical research.
Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, FVIII intolerance and uveitis.